Skip to main content
Clinical Trials/NCT06246084
NCT06246084
Completed
N/A

INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy

Dana-Farber Cancer Institute1 site in 1 country76 target enrollmentFebruary 15, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Dana-Farber Cancer Institute
Enrollment
76
Locations
1
Primary Endpoint
Engagement Rate of Intervention
Status
Completed
Last Updated
last year

Overview

Brief Summary

This research is being done to pilot an intervention which aims to improve participants' experiences on Endocrine Therapy.

The name of the intervention used in this research study is:

Endocrine Therapy Education Program (a brief, video-based intervention)

Detailed Description

This research study is a randomized pilot study to determine whether a brief-video based intervention program can improve experiences of Endocrine Therapy (ET). Participants will be randomized into one of two groups: Group A: Endocrine Therapy Education Intervention vs. Group B Wait-list Control Group. Randomization means a participant is placed into a study group by chance. The research study procedures include screening for eligibility, in-clinic visits, and survey questionnaires. Participation in this research study is expected to last 3 months. It is expected that about 60 people will take part in this research study.

Registry
clinicaltrials.gov
Start Date
February 15, 2024
End Date
December 23, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ann H. Partridge, MD, MPH

Principal Investigator

Dana-Farber Cancer Institute

Eligibility Criteria

Inclusion Criteria

  • Biologically female
  • About to begin or just started (within four weeks of starting) an oral form of ET (either tamoxifen or AI)
  • 18 years of age or older
  • English fluency for reading and writing.
  • Computer literacy (ability to watch videos and fill out questionnaires online)

Exclusion Criteria

  • Adults unable to consent
  • Individuals with metastatic cancer
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners

Outcomes

Primary Outcomes

Engagement Rate of Intervention

Time Frame: 6 weeks

Adequate engagement of the intervention is defined as a click-to-open rate of 60% or over for the intervention group.

Intervention Satisfaction Questionnaire Mean Score Group A

Time Frame: At 6 weeks

Responses will be analyzed to determine a mean score for each item for the intervention group. The Intervention Satisfaction Questionnaire includes 9 items rated on a 1 to 10 scale.

Intervention Satisfaction Questionnaire Mean Score Group B

Time Frame: At 14 weeks

Responses will be analyzed to determine a mean score for each item for the control group (following the release of the intervention educational videos). The Intervention Satisfaction Questionnaire includes 9 items rated on a 1 to 10 scale.

Study Sites (1)

Loading locations...

Similar Trials